CIK 0001512762 · Accelerated filer<br>Smaller reporting company
Coherus Oncology, Inc.
Sign in to watch- Ticker
- CHRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273615821
- Phone
- (650) 649-3530
- Business address
- C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
- Former names
- Coherus BioSciences, Inc., BioGenerics, Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes President and CEO gave up 17,867 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 6,297 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 6,404 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 5,916 shares (to pay taxes)
- 4/A Derivatives Options or other derivatives
- 3/A Insider 3/A
- 4/A Derivatives Options or other derivatives
- 3/A Insider 3/A
- 8-K Event Material agreement
- SC 13G Stake Amended Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
Page 27 of 47 · 923 filings